Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

Allos Therapeutics, Inc. (MM) (ALTH)

Allos Therapeutics, Inc. (MM)
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ALTH
DateTimeSourceHeadlineSymbolCompany
10/11/200814:20Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
10/11/200814:17Business WireFour Pralatrexate (PDX) Studies to Be Presented at the 50th Annual Meeting of the American Society of HematologyNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/11/200822:09Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/11/200821:05Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/11/200821:00Business WireAllos Therapeutics Reports 2008 Third Quarter ResultsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
04/11/200813:00Business WireAllos Therapeutics to Present at the Rodman & Renshaw 10th Annual Healthcare ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
30/10/200821:06Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
30/10/200821:06Edgar (US Regulatory)Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
30/10/200820:00Business WireFour Pralatrexate (PDX) Studies Accepted for Presentation at the 50th Annual Meeting of the American Society of HematologyNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
30/10/200820:00Business WireFour Pralatrexate (PDX) Studies Accepted for Presentation at the 50th Annual Meeting of the American Society of HematologyNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
29/10/200812:00Business WireAllos Therapeutics to Report Third Quarter 2008 Results on November 5, 2008NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
01/10/200813:00Business WireAllos Therapeutics to Present at the JMP Healthcare Focus ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
25/09/200814:05Edgar (US Regulatory)Allos Therapeutics Inc - Confidential Treatment Order (CT ORDER)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
03/09/200822:06Edgar (US Regulatory)Allos Therapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
03/09/200822:01Edgar (US Regulatory)Allos Therapeutics Inc - Statement of Changes in Beneficial Ownership (4)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
02/09/200813:00Business WireAllos Therapeutics to Present at the 3rd Annual Citi Biotech DayNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
28/08/200821:00Business WireAllos Therapeutics to Present at the NewsMakers in the Biotech Industry ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
27/08/200822:09Edgar (US Regulatory)Allos Therapeutics Inc - Confidential Treatment Order (CT ORDER)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
27/08/200822:07Edgar (US Regulatory)Allos Therapeutics Inc - Confidential Treatment Order (CT ORDER)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
27/08/200822:07Edgar (US Regulatory)Allos Therapeutics Inc - Confidential Treatment Order (CT ORDER)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
27/08/200822:06Edgar (US Regulatory)Allos Therapeutics Inc - Confidential Treatment Order (CT ORDER)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
25/08/200821:17Edgar (US Regulatory)Allos Therapeutics Inc - Amended Annual Report (10-K/A)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/08/200822:30Edgar (US Regulatory)Allos Therapeutics Inc - Quarterly Report (10-Q)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/08/200821:03Edgar (US Regulatory)Allos Therapeutics Inc - Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
05/08/200821:00Business WireAllos Therapeutics Reports 2008 Second Quarter ResultsNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
23/07/200813:00Business WireAllos Therapeutics to Present at the Bank of America 2008 Specialty Pharmaceuticals ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
22/07/200813:00Business WireAllos Therapeutics to Report Second Quarter 2008 Results on August 5, 2008NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
21/07/200813:06Edgar (US Regulatory)Allos Therapeutics Inc - Current report filing (8-K)NASDAQ:ALTHAllos Therapeutics, Inc. (MM)
21/07/200813:00Business WireAllos Therapeutics Initiates Phase 2 Study of PDX in Patients with Advanced or Metastatic Relapsed Transitional Cell Carcinoma oNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
03/07/200813:00Business WireAllos Therapeutics to Present at the Collins Stewart Fourth Annual Growth ConferenceNASDAQ:ALTHAllos Therapeutics, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:ALTH

Your Recent History

Delayed Upgrade Clock